Skip to main content
Log in

Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice

  • Article
  • Published:
Lipids

Abstract

The effect of oral administration of purified (95%) eicosapentaenoic acid on serum lipids, hepatic peroxisomal enzymes, antioxidant enzymes and lipid peroxidation was compared with that of palmitic acid fed mice and corresponding controls. After 10 d, a dose of 1000 mg eicosapentaenoic acid per day/kg body weight lowered serum triglycerides by 45%, while no significant change in serum cholesterol level was noted in comparison to palmitic acid fed mice and controls. Hepatic acyl-CoA oxidase and catalase activities increased by 50% and 30%, respectively, in the eicosapentaenoic acid fed group. In addition, the hepatic reduced glutathione content and the activities of glutathione transferase, glutathione peroxidase and glutathione reductase, increased significantly during eicosapentaenoic acid treatment. The levels of hepatic lipid peroxides were lower after eicosapentaenoic acid feeding, while no significant change was noted in the palmitic acid fed mice when compared to the controls. Taken together, the present data demonstrate for the first time that at hypolipidemic doses eicosapentaenoic acid feeding i) enhances the hepatic antioxidant defense, and ii) does not cause a significant differential induction of the two peroxisomal enzymes, acyl-CoA oxidase and catalase, as was noted after administration of hypolipidemic peroxisome proliferating compounds, such as clofibrate in rodents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CMC:

sodium carboxymethyl cellulose

EDTA:

ethylenediaminetetraacetic acid

EPA:

eicosapentaenoic acid (20∶5n−3)

GSH:

reduced glutathione

HEPES:

N-[2-hydroxyethyl]piperazineN′-[2-ethanesulfonic acid]

HPLC:

high-performance liquid chromatography

TBARS:

thiobarbituric acid reactive substances

References

  1. Sirtori, C.R., Catapano, A., and Paoletti, R. (1977)Atheroscler. Rev. 2, 113–153.

    CAS  Google Scholar 

  2. Havel, R.J., and Kane, J.P. (1973)Annu Rev. Pharmacol. 13, 287–308.

    Article  PubMed  CAS  Google Scholar 

  3. Moody, D.E., and Reddy, J.K. (1978)Am. J. Pathol. 90, 435–446.

    PubMed  CAS  Google Scholar 

  4. Fahal, W.E., Lawani, N.D., Watanabe, T., Goel, S.K., and Reddy, J.K. (1984)Proc. Natl. Acad. Sci. USA 81, 7827–7830.

    Article  Google Scholar 

  5. Goel, S.K., Lawani, N.D., and Reddy, J.K. (1986)Cancer Res. 46, 1324–1330.

    PubMed  CAS  Google Scholar 

  6. Reddy, J.K., Azarnoff, D.L., and Hignite, C.E. (1986)Nature 283, 397–398.

    Article  Google Scholar 

  7. Reddy, J.K., Lalwani, N.D., Reddy, M.K., and Qureshi, S. (1982)Cancer Res. 42, 259–266.

    PubMed  CAS  Google Scholar 

  8. Reddy, J.K., and Lalwani, N.D. (1983)CRC Crit. Rev. Toxicol. 12, 1–58.

    CAS  Google Scholar 

  9. Connor, W.E., Lin, D.S., and Harris, W.S. (1981)Arteriosclerosis 1, 363a.

    Google Scholar 

  10. Goodnight, S.H., Harris, W.S., Connor, W.E., and Illingworth, D.R. (1982)Arteriosclerosis 2, 87–113.

    PubMed  CAS  Google Scholar 

  11. Nestel, P.J., Connor, W.E., Reardon, M.F., Connor, S., Wong, S., and Boston, R. (1984)J. Clin. Invest. 74, 82–89.

    PubMed  CAS  Google Scholar 

  12. Reddy, B.S., Burill, C., and Rigotty, J. (1991)Cancer Res. 51, 487–491.

    PubMed  CAS  Google Scholar 

  13. Beck, S.A., Smith, K.L., and Tisdale, M.J. (1991)Cancer Res. 51, 6089–6093.

    PubMed  CAS  Google Scholar 

  14. Small, G.M., Burdett, K., and Donnock, M.J. (1985)Biochem. J. 227, 205–210.

    PubMed  CAS  Google Scholar 

  15. Lück, H. (1963)Methods Enzym. Anal. 2, 885–887.

    Google Scholar 

  16. Flohé, L., and Günzler, K.A. (1984)Methods Enzymol. 105, 114–121.

    Article  PubMed  Google Scholar 

  17. Habig, W.H., Pabst, M.J., and Jakoby, W.B. (1974)J. Biol. Chem. 249, 7130–7139.

    PubMed  CAS  Google Scholar 

  18. Eklöw, W.L., Moldén, S.P., and Orrenius, S. (1984)Eur. J. Biochem. 138, 459–463.

    Article  PubMed  Google Scholar 

  19. Svardal, A.M., Mansoor, M.A., and Ueland, P.M. (1990)Anal. Biochem. 184, 338–346.

    Article  PubMed  CAS  Google Scholar 

  20. Ohkawa, H., Ohishi, N., and Yagi, K. (1979)Anal. Biochem. 95, 351–358.

    Article  PubMed  CAS  Google Scholar 

  21. Aarsland, A., Lundquist, M., Børresten, B., and Berge, R.K. (1990)Lipids 25, 546–548.

    PubMed  CAS  Google Scholar 

  22. Berge, R.K., and Bakke, O.M. (1981)Biochem. Pharmacol. 30, 2251–2256.

    Article  PubMed  CAS  Google Scholar 

  23. Lalwani, N.D., Reddy, M.K., Qureshi, S.A., and Reddy, J.K. (1981)Carcinogenesis 2, 645–650.

    PubMed  CAS  Google Scholar 

  24. Kappus, H., and Sies, H. (1981)Experientia 37, 1233–1241.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Demoz, A., Willumsen, N. & Berge, R.K. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids 27, 968–971 (1992). https://doi.org/10.1007/BF02535573

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02535573

Keywords

Navigation